Clifford Chance
Clifford Chance advises on Hygeia Healthcare's US$282 million Hong Kong IPO
29 June 2020
- Liu Fang , Tianning Xiang , Lorna Lyu , Erxin Lu , Emma Bao , Haoze Zheng
- Hong Kong , Beijing , Shanghai
Clifford Chance advises on Hygeia Healthcare's US$282 million Hong Kong IPO
Leading international law firm Clifford Chance has advised Morgan Stanley, Haitong International Securities and Huatai Financial Holdings as the lead underwriters on Hygeia Healthcare Holdings Co., Limited's US$282 million (HK$2.22 billion) IPO and listing on the main board of the Stock Exchange of Hong Kong. Hygeia Healthcare is a Chinese oncology healthcare group based in Shanghai. The public tranche of this offering attracted more than 300,000 applications with over 600 times oversubscription, making it one of most sought after IPOs this year.
Partner Fang Liu who led on the deal said, "Our team was very pleased to assist on this leading medical services provider's successful IPO, which once again showcased our strong execution capabilities in handling complex transactions, and our healthcare sector expertise."
Fang and partner Tianning Xiang co-led the deal and were supported by counsel Lorna Lyu, senior associate Erxin Lu, associates Emma Bao, Alex Feng and Haoze Zheng, and trainees Jiawei Zhao, Astrid Zhuang and Ada Zheng.
高伟绅助力海吉亚医疗2.82亿美元香港首次公开发行
国际领先律师事务所高伟绅就海吉亚医疗控股有限公司（“海吉亚医疗”）2.82亿美元（约合22.2亿港元）首次公开发行及香港联交所主板上市，担任牵头承销商摩根士丹利、海通及华泰的国际法律顾问。海吉亚医疗是一家总部位于上海的肿瘤医疗集团。该公开发行部分吸引逾30万份认购申请，超额认购过600倍，是今年最受追捧的首次公开发行之一。
项目牵头合伙人方刘律师表示，“我们非常荣幸参与业界领先的海吉亚医疗成功香港上市。此交易再次突显了高伟绅处理复杂交易的高超技能及在医疗健康领域的行业经验。”
此交易由合伙人方刘和向天宁共同牵头，团队包括吕娜、陆尔馨、包宸、冯也威、郑镐泽、赵家炜、庄立平和郑喻丹。
